Metabolomics Workbench : NIH Data Repository

Analysis	Metabolite Name	Measured Value	Units	Sample	Treatment
Reversed phase NEGATIVE ION MODE	phenylacetate	0.2350	Peak area	Feces	Angiotensin II
Reversed phase NEGATIVE ION MODE	phenylacetate	0.2350	Peak area	Feces	Saline
Reversed phase NEGATIVE ION MODE	phenylacetate	0.5515	Peak area	Feces	Saline
Reversed phase NEGATIVE ION MODE	phenylacetate	0.6255	Peak area	Feces	Angiotensin II
Reversed phase NEGATIVE ION MODE	phenylacetate	0.6651	Peak area	Feces	Angiotensin II
Reversed phase NEGATIVE ION MODE	phenylacetate	0.7688	Peak area	Feces	Angiotensin II
Reversed phase NEGATIVE ION MODE	phenylacetate	0.8150	Peak area	Feces	Saline
Reversed phase NEGATIVE ION MODE	phenylacetate	1.1850	Peak area	Feces	Angiotensin II
Reversed phase NEGATIVE ION MODE	phenylacetate	1.1880	Peak area	Feces	Angiotensin II
Reversed phase NEGATIVE ION MODE	phenylacetate	1.2040	Peak area	Feces	Saline
Reversed phase NEGATIVE ION MODE	phenylacetate	1.2182	Peak area	Feces	Angiotensin II
Reversed phase NEGATIVE ION MODE	phenylacetate	1.6778	Peak area	Feces	Saline
Reversed phase NEGATIVE ION MODE	phenylacetate	1.8946	Peak area	Feces	Saline